Cibc-World-Markets

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,844
Total Value
12711081325
Accession Number
0001056527-25-000020
Form Type
13F-HR
Manager Name
Cibc-World-Markets
Data Enrichment
95% identified
1,759 identified85 unidentified

Holdings

1,844 positions • $12.7B total value
Manager:
Search and click to pin securities to the top
Prime Medicine, Inc.
Shares:12.6K
Value:$25.0K
% of Portfolio:0.0% ($25.0K/$12.7B)
PLAYSTUDIOS, Inc.
Shares:19.5K
Value:$24.8K
% of Portfolio:0.0% ($24.8K/$12.7B)
Regulus Therapeutics Inc.
Shares:14.0K
Value:$24.5K
% of Portfolio:0.0% ($24.5K/$12.7B)
BRC Inc.
Shares:11.7K
Value:$24.5K
% of Portfolio:0.0% ($24.5K/$12.7B)
Nerdy Inc.
Shares:17.2K
Value:$24.5K
% of Portfolio:0.0% ($24.5K/$12.7B)
Shares:10.3K
Value:$23.3K
% of Portfolio:0.0% ($23.3K/$12.7B)
Alector, Inc.
Shares:18.2K
Value:$22.4K
% of Portfolio:0.0% ($22.4K/$12.7B)
Beauty Health Co
Shares:16.5K
Value:$22.1K
% of Portfolio:0.0% ($22.1K/$12.7B)
Stereotaxis, Inc.
Shares:12.5K
Value:$22.1K
% of Portfolio:0.0% ($22.1K/$12.7B)
PROKIDNEY CORP.
Shares:24.7K
Value:$21.6K
% of Portfolio:0.0% ($21.6K/$12.7B)
WM TECHNOLOGY, INC.
Shares:19.1K
Value:$21.6K
% of Portfolio:0.0% ($21.6K/$12.7B)
Nkarta, Inc.
Shares:11.7K
Value:$21.6K
% of Portfolio:0.0% ($21.6K/$12.7B)
C4 Therapeutics, Inc.
Shares:13.3K
Value:$21.4K
% of Portfolio:0.0% ($21.4K/$12.7B)
Editas Medicine, Inc.
Shares:18.4K
Value:$21.3K
% of Portfolio:0.0% ($21.3K/$12.7B)
Zentalis Pharmaceuticals, Inc.
Shares:12.7K
Value:$20.2K
% of Portfolio:0.0% ($20.2K/$12.7B)
Coherus BioSciences, Inc.
Shares:24.9K
Value:$20.1K
% of Portfolio:0.0% ($20.1K/$12.7B)
Wheels Up Experience Inc.
Shares:19.9K
Value:$20.1K
% of Portfolio:0.0% ($20.1K/$12.7B)
Blink Charging Co.
Shares:21.3K
Value:$19.6K
% of Portfolio:0.0% ($19.6K/$12.7B)
Lyell Immunopharma, Inc.
Shares:35.7K
Value:$19.2K
% of Portfolio:0.0% ($19.2K/$12.7B)
Neumora Therapeutics, Inc.
Shares:18.9K
Value:$18.9K
% of Portfolio:0.0% ($18.9K/$12.7B)